Abstract:Objective To observe the effect of recombinant human programmed cell death 5 (rhPDCD5) protein on the apoptosis of human bladder cancer cell line BIU87 induced by cisplatin (DDP) and to investigate its mechanism.Methods Inhibition rates of bladder cancer cell line BIU87 intervened by rhPDCD5 protein and/or DDP with different concentrations were tested by cell counting kit-8 (CCK-8).The morphological changes of cells were detected by Hoechst 33342 staining.The cells apoptosis rates were examined by flow cytometry.The changes of expression of the cysteinyl aspartate specific proteinase-3 (Caspase-3) and B-cell lymphoma/Leukemia-2 (bcl-2) were measured by Western blotting analysis.Results CCK-8 showed that rhPDCD5 protein or/and DDP could inhibit the proliferation of BIU87 cells effectively.Hoechst 33342 staining showed that the positive cells rate of cells treated with rhPDCD5 protein and DDP (31.62 ± 2.33)％ was obviously higher than that only treated with rhPDCD5 protein (9.61 ± 0.42) ％ or DDP (14.12 ± 0.24) ％,the difference was significant (F =221.42,P ＜ 0.01).The flow cytometry (FCM) showed that the apoptosis rate of cells treated with rhPDCD5 protein and DDP (58.74 ± 3.48)％ was obviously increased than that only treated with rhPDCD5 protein (18.84 ± 1.23) ％ or DDP (21.25 ± 2.27) ％,the difference was significant (F =228.93,P ＜ 0.01).Compared with the group only treated with rhPDCD5 protein or DDP,the expression of Caspase-3 of the group treated with rhPDCD5 protein and DDP was significantly up-regulated (F =12.60,P ＜ 0.01) and the expression of bcl-2 was significantly down-regulated (F =12.20,P ＜ 0.01).Conclusion rhPDCD5 protein can induce the apoptosis of BIU87 cells,and accelerate the apoptosis of BIU87 cells induced by DDP.rhPDCD5 protein may reduce the expression of bcl-2 protein and increase activation of Caspase-3 to play its role in promoting apoptosis.

Programmed cell death 5 enhance inhibitory effect of cisplatin on growth of colorectal carcinoma cells in vivo

Transfection of PDCD5 Effect on the Biological Behavior of Tumor Cells and Sensitized Gastric Cancer Cells to Cisplatin-Induced Apoptosis

The Interaction Between PDCD4 and YB1 is Critical for Cervical Cancer Stemness and Cisplatin Resistance.

Effect of recombinant human programmed cell death 5 protein on cell apoptosis of human bladder cancer cell line BIU87 induced by cisplatin and its mechanism

Recombinant Human PDCD5 Sensitizes Chondrosarcomas to Cisplatin Chemotherapy in Vitro and in Vivo

(−)-Epigallocatechin-3-gallate derivatives combined with cisplatin exhibit synergistic inhibitory effects on non-small-cell lung cancer cells

Short Interfering RNA Against the PDCD5 Attenuates Cell Apoptosis and Caspase-3 Activity Induced by Bax Overexpression

Recombinant Human PDCD5 Protein Enhances Chemosensitivities of Hematologic Malignancies

Recombinant Human PDCD5 Protein Enhances Chemosensitivity of Breast Cancer in Vitro and in Vivo.

Cisplatin Plus Anti-Pd-1 Antibody Enhanced Treatment Efficacy in Advanced Esophageal Squamous Cell Carcinoma.

DAP5 ameliorates cisplatin-induced apoptosis of renal tubular cells.

Pan-cancer Analysis of Oncogenic Role of Programmed Cell Death 2 Like (PDCD2L) and Validation in Colorectal Cancer

Integrated Global Proteomic and Phosphoproteomic Analysis of Cisplatin-Induced Apoptosis in A549 Cells

Potent Antitumor Activities of Recombinant Human PDCD5 Protein in Combination with Chemotherapy Drugs in K562 Cells.

Low programmed cell death 5 expression is a prognostic factor in ovarian cancer.

CIP2A depletion potentiates the chemosensitivity of cisplatin by inducing increased apoptosis in bladder cancer cells.

Transgenic human programmed cell death 5 expression in mice suppresses skin cancer development by enhancing apoptosis

Programmed cell death 11 modulates but not entirely relies on p53-HDM2 loop to facilitate G2/M transition in colorectal cancer cells

Expression of Programmed Cell Death 5 Gene Involves in Regulation of Apoptosis in Gastric Tumor Cells

Cisplatin Pretreatment Enhances Anti-Tumor Activity of Cytokine-Induced Killer Cells

Sensitizing effect of recombinant human PDCD5 protein on chemotherapy of acute monocytic leukemia cell line U937 and its mechanism]